Inseyah Bagasrawala

Biogen, Morrisville, NC, United States 
AAV Gene therapy, NMDA receptors, cortical development, neuromuscular diseases, schizophrenia, epilepsy
"Inseyah Bagasrawala"


Sign in to add collaborator
Srdjan D. Antic collaborator (Neurotree)
Steven J. Gray collaborator (Neurotree)
Pasko Rakic collaborator (Neurotree)
Thomas L. Schwarz collaborator
Nenad Sestan collaborator (Neurotree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hines TJ, Tadenev ALD, Lone MA, et al. (2021) Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1. Journal of Anatomy
Ortega JA, Memi F, Radonjic N, et al. (2017) The Subventricular Zone: A Key Player in Human Neocortical Development. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 1073858417691009
Radonjic N, Bagasrawala I, Zecevic N. (2017) 727. Increased Levels of Kynurenic Acid Affect Human Developing Brain Biological Psychiatry. 81: S295
Bagasrawala I, Zecevic N, Radonjić NV. (2016) N-Methyl D-Aspartate Receptor Antagonist Kynurenic Acid Affects Human Cortical Development. Frontiers in Neuroscience. 10: 435
Bagasrawala I, Memi F, V Radonjić N, et al. (2016) N-Methyl d-Aspartate Receptor Expression Patterns in the Human Fetal Cerebral Cortex. Cerebral Cortex (New York, N.Y. : 1991)
See more...